Executive Chairman and Interim Chief Executive Officer and President at TG Therapeutics, Inc.
Michael S. Weiss, 51, has served as TG's Executive Chairman, Chief Executive Officer and President since December 2011. Mr. Weiss is a co-founder of, and has been a managing partner and principal of Opus Point Partners since 2009. Mr. Weiss earned his J.D. from Columbia Law School and his B.S. in Finance from The University at Albany. He began his professional career as a lawyer with Cravath, Swaine & Moore. In 1999, Mr. Weiss founded Access Oncology which was later acquired by Keryx Biopharmaceuticals, Inc. in 2004. Following the merger, Mr. Weiss remained as CEO of Keryx and grew the company to close to a $1 billion market capitalization co ...
Source: TG Therapeutics, Inc. on 04/28/2017
By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Michael S. Weiss. More specifically, you'll be able to:
Access over 170,000 executive and board member profiles.
Example: Michael S. Weiss
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.